|
| 38053237 | Treatment of high-risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes. | Pediatr Blood Cancer | 2024 |
| 38062123 | Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232. | Leukemia | 2024 |
| 37890117 | Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. | J Clin Oncol | 2024 |
| 36256911 | Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. | J Clin Oncol | 2023 |
| 38023200 | Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers. | Front Oncol | 2023 |
| 37489549 | Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2023 |
| 37961674 | Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia. | Res Sq | 2023 |
| 37487146 | Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. | J Clin Oncol | 2023 |
| 37592363 | Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia. | Pediatr Blood Cancer | 2023 |
| 37556734 | Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study. | Blood | 2023 |
| 37517410 | Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. | Lancet Oncol | 2023 |
| 37790759 | Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients. | Front Oncol | 2023 |
| 37503171 | Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children. | Res Sq | 2023 |
| 37535886 | Physician Perceptions of and Barriers to Pediatric Palliative Care for Children With Cancer in Brazil. | JCO Glob Oncol | 2023 |
| 37259259 | Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631. | Pediatr Blood Cancer | 2023 |
| 37257143 | Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse. | J Clin Oncol | 2023 |
| 37157018 | Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932. | Leukemia | 2023 |
| 37216686 | The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. | Blood | 2023 |
| 37407142 | Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial. | Lancet Haematol | 2023 |
| 37207162 | Impact of hospital characteristics on implementation of a Pediatric Early Warning System in resource-limited cancer hospitals. | Front Oncol | 2023 |
| 37433316 | Effect of paediatric early warning systems (PEWS) implementation on clinical deterioration event mortality among children with cancer in resource-limited hospitals in Latin America: a prospective, multicentre cohort study. | Lancet Oncol | 2023 |
| 37001051 | Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. | Blood | 2023 |
| 36966262 | Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932. | Leukemia | 2023 |
| 37194498 | Outcomes of SARS-CoV-2 infection in 126 children and adolescents with central nervous system tumors. | Pediatr Blood Cancer | 2023 |
| 36725118 | Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. | Lancet Haematol | 2023 |
| 36656580 | Ideal vs Actual Timing of Palliative Care Integration for Children With Cancer in Latin America. | JAMA Netw Open | 2023 |
| 36788461 | Interdisciplinary care of pediatric oncology patients: A survey of clinicians in Central America and the Caribbean. | Pediatr Blood Cancer | 2023 |
| 36780591 | Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region. | JCO Glob Oncol | 2023 |
| 36576946 | Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia. | Blood Adv | 2023 |
| 36603187 | Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report. | Blood | 2023 |
| 36861410 | <i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study. | Haematologica | 2023 |
| 36073348 | Regional adaptation of the education in palliative and end-of-life Care Pediatrics (EPEC-Pediatrics) curriculum in Eurasia. | Cancer Med | 2023 |
| 36383283 | An international multicenter survey reveals health care providers' knowledge gap in childhood central nervous system tumors. | Eur J Pediatr | 2023 |
| 36325891 | Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia. | Haematologica | 2023 |
| 34725453 | Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. | Leukemia | 2022 |
| 35411095 | JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia. | Leukemia | 2022 |
| 35575404 | Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. | J Natl Cancer Inst | 2022 |
| 35552709 | Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia. | J Natl Cancer Inst | 2022 |
| 36580335 | Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. | JAMA Netw Open | 2022 |
| 36530983 | Outcomes for critical illness in children with cancer: Analysis of risk factors for adverse outcome and resource utilization from a specialized center in Mexico. | Front Oncol | 2022 |
| 36228982 | Design and methods of a randomized web-based physical activity intervention among children with cancer: A report from the Children's Oncology Group. | Contemp Clin Trials | 2022 |
| 35953257 | Cancer treatment decision-making among parents of paediatric oncology patients in Guatemala: a mixed-methods study. | BMJ Open | 2022 |
| 36050548 | The genomic landscape of pediatric acute lymphoblastic leukemia. | Nat Genet | 2022 |
| 36083863 | Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2022 |
| 35067925 | Impact of the COVID-19 pandemic on pediatric oncology providers globally: A mixed-methods study. | Cancer | 2022 |
| 35007127 | Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. | J Clin Oncol | 2022 |
| 35271306 | Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. | J Clin Oncol | 2022 |
| 35201611 | Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. | Cancer | 2022 |
| 35172563 | Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial. | Haematologica | 2022 |
| 35084434 | Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. | JAMA Oncol | 2022 |